1 | rise | 4,213 |
2 | increment | 1,029 |
3 | increments | 550 |
4 | rises | 396 |
5 | surge | 296 |
6 | resurgence | 91 |
7 | upshift | 38 |
8 | surges | 34 |
9 | shift-up | 10 |
10 | sd-eeg | 6 |
11 | end-spurt | 4 |
12 | quickened | 3 |
13 | spirooxetanes | 3 |
14 | subrandomization | 3 |
15 | -771 | 2 |
16 | 3-alkyl-1h-pyrroles | 2 |
17 | 318k | 2 |
18 | 471.71 | 2 |
19 | 5-oxo-pentanenitriles | 2 |
20 | diketone | 2 |
21 | hanges | 2 |
22 | mprovement | 2 |
23 | stress-elicited | 2 |
24 | subject-by-subject | 2 |
25 | wiesław | 2 |
26 | 0.02- | 1 |
27 | 1,2-diphenylbenzimidazoles | 1 |
28 | 1,3,5-triarylpyrazoles | 1 |
29 | 2.1m | 1 |
30 | 2gkg | 1 |
31 | 3,3-dichloroindolin-2-ones | 1 |
32 | 3-alkylprop-1-en-3-ols | 1 |
33 | 3-cyanobenzofurans | 1 |
34 | 432.6 | 1 |
35 | 5-cyclohexylamino-3-methyl-1- | 1 |
36 | a1-domain | 1 |
37 | buminemia | 1 |
38 | capitulation | 1 |
39 | co3o4-omc | 1 |
40 | fieled | 1 |
41 | mannose-6-p | 1 |
42 | n-phenyl-5-phenyl-1,3,4-thiadiazol-2-amine | 1 |
43 | teaching-sessions | 1 |
44 | tryphine | 1 |
45 | vitalities | 1 |
46 | ∼37.3°c | 1 |
47 | ≥15,000/mm³ | 1 |
1 | -771 | 2 |
2 | 0.02- | 1 |
3 | 1,2-diphenylbenzimidazoles | 1 |
4 | 1,3,5-triarylpyrazoles | 1 |
5 | 2.1m | 1 |
6 | 2gkg | 1 |
7 | 3,3-dichloroindolin-2-ones | 1 |
8 | 3-alkyl-1h-pyrroles | 2 |
9 | 3-alkylprop-1-en-3-ols | 1 |
10 | 3-cyanobenzofurans | 1 |
11 | 318k | 2 |
12 | 432.6 | 1 |
13 | 471.71 | 2 |
14 | 5-cyclohexylamino-3-methyl-1- | 1 |
15 | 5-oxo-pentanenitriles | 2 |
16 | a1-domain | 1 |
17 | buminemia | 1 |
18 | capitulation | 1 |
19 | co3o4-omc | 1 |
20 | diketone | 2 |
21 | end-spurt | 4 |
22 | fieled | 1 |
23 | hanges | 2 |
24 | increment | 1,029 |
25 | increments | 550 |
26 | mannose-6-p | 1 |
27 | mprovement | 2 |
28 | n-phenyl-5-phenyl-1,3,4-thiadiazol-2-amine | 1 |
29 | quickened | 3 |
30 | resurgence | 91 |
31 | rise | 4,213 |
32 | rises | 396 |
33 | sd-eeg | 6 |
34 | shift-up | 10 |
35 | spirooxetanes | 3 |
36 | stress-elicited | 2 |
37 | subject-by-subject | 2 |
38 | subrandomization | 3 |
39 | surge | 296 |
40 | surges | 34 |
41 | teaching-sessions | 1 |
42 | tryphine | 1 |
43 | upshift | 38 |
44 | vitalities | 1 |
45 | wiesław | 2 |
46 | ∼37.3°c | 1 |
47 | ≥15,000/mm³ | 1 |
1 | 5-cyclohexylamino-3-methyl-1- | 1 |
2 | 0.02- | 1 |
3 | 471.71 | 2 |
4 | -771 | 2 |
5 | 432.6 | 1 |
6 | buminemia | 1 |
7 | co3o4-omc | 1 |
8 | ∼37.3°c | 1 |
9 | fieled | 1 |
10 | quickened | 3 |
11 | stress-elicited | 2 |
12 | resurgence | 91 |
13 | surge | 296 |
14 | tryphine | 1 |
15 | n-phenyl-5-phenyl-1,3,4-thiadiazol-2-amine | 1 |
16 | diketone | 2 |
17 | rise | 4,213 |
18 | sd-eeg | 6 |
19 | 2gkg | 1 |
20 | 318k | 2 |
21 | 2.1m | 1 |
22 | a1-domain | 1 |
23 | capitulation | 1 |
24 | subrandomization | 3 |
25 | mannose-6-p | 1 |
26 | shift-up | 10 |
27 | hanges | 2 |
28 | surges | 34 |
29 | vitalities | 1 |
30 | 5-oxo-pentanenitriles | 2 |
31 | 3-alkyl-1h-pyrroles | 2 |
32 | 1,2-diphenylbenzimidazoles | 1 |
33 | 1,3,5-triarylpyrazoles | 1 |
34 | spirooxetanes | 3 |
35 | 3,3-dichloroindolin-2-ones | 1 |
36 | rises | 396 |
37 | 3-alkylprop-1-en-3-ols | 1 |
38 | 3-cyanobenzofurans | 1 |
39 | teaching-sessions | 1 |
40 | increments | 550 |
41 | subject-by-subject | 2 |
42 | upshift | 38 |
43 | increment | 1,029 |
44 | mprovement | 2 |
45 | end-spurt | 4 |
46 | wiesław | 2 |
47 | ≥15,000/mm³ | 1 |